Aspilia pluriseta
Aspilia pluriseta · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Aspilia pluriseta is a botanical species recognized for its significant medicinal potential, particularly regarding its diverse antiviral activities. Research indicates that the plant contains a rich profile of bioactive chemicals, including alkanes, anthraquinones, flavonoids, and terpenoids. These therapeutic compounds are found throughout various plant parts, specifically within the leaves, stems, and roots. Studies utilizing ethanolic extracts, 80% ethanolic extracts, extract fractions, and root extracts have demonstrated efficacy against various pathogens. Specifically, the plant has shown promise in combating conditions caused by Candida albicans, Escherichia coli, Mycobacterium tuberculosis, and Staphylococcus aureus.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Common Names
Aspilia pluriseta is a botanical species frequently referred to by its common name, the Dwarf Aspilia. This plant is recognized for its compact growth habit and distinct floral characteristics. Within the botanical community, understanding its specific classification helps researchers distinguish it from larger relatives. Its unique identity as the Dwarf Aspilia makes it a notable subject for those studying regional flora. Consequently, mastering its nomenclature is essential for anyone documenting diverse plant life.
Sources: Catalogue of Life (COL)
Taxonomy
Aspilia pluriseta is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, it is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its specialized evolutionary lineage. As a member of the genus Aspilia, it displays unique morphological traits characteristic of its group. Finally, this plant is a distinguished representative of the diverse family Asteraceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Aspilia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aspilia pluriseta is a plant species with a diverse distribution spanning several regions across the African continent. In East Tropical Africa, it can be found growing within the borders of Uganda. Moving toward Northeast Tropical Africa, the species also inhabits the areas encompassing Sudan and South Sudan. Its presence extends further south into the tropical reaches of Mozambique, Zambia, and Zimbabwe. This wide geographical range highlights the plant's ability to thrive in various environments throughout Southern and Eastern Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aspilia pluriseta is a self-supporting herb that occupies a distinct niche in its natural habitat. This plant maintains a modest presence, typically reaching a maximum height of only 0.5 meters. However, under certain conditions, its growth can extend to a maximum height of 1.5 meters. These physical characteristics define its structural role within its surrounding ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Aspilia pluriseta has demonstrated significant antiviral activity during investigations into Rwandan medicinal plants used for treating infections. Specifically, studies targeting human immunodeficiency virus type-1 (HIV-1) identified the leaf extracts of this Asteraceae species as having promising therapeutic potential. Unlike many other tested plants, its extracts exhibited an interesting selectivity index higher than one, suggesting a favorable balance between efficacy and safety. This finding highlights the plant's importance in the traditional medicinal landscape of Rwanda for managing viral threats. Such results underscore the necessity of exploring plant-based compounds for the development of new antiviral treatments.
Compounds
Aspilia pluriseta has demonstrated significant therapeutic potential through the presence of various bioactive phytochemicals. Qualitative analysis of its extract fractions revealed the presence of terpenoids, flavonoids, and anthraquinones. Furthermore, gas chromatography-mass spectrometry identified an abundance of fatty acid esters within the plant. The chemical profile is further characterized by the detection of several alkanes. These diverse compounds support the scientific validation of the species as a promising source for discovering novel antimicrobial agents.
Conditions
Aspilia pluriseta demonstrates significant antimicrobial properties by treating several pathogens, including Candida albicans, Escherichia coli, Staphylococcus aureus, and Mycobacterium tuberculosis. Specifically, methanolic extracts of the plant show high inhibitory activity against Mycobacterium tuberculosis and considerable potency against the other listed microbes. Beyond its antimicrobial effects, the plant also exhibits immunomodulatory capabilities. Research indicates that Aspilia pluriseta possesses inhibitory activity against the alternative pathway of the complement system. These diverse biological activities validate its potential as a source for discovering novel therapeutic agents.
Preparations
Aspilia pluriseta is prepared as 80% ethanolic extracts to investigate its antiviral activity against HIV-1. This plant is also prepared as ethanolic extracts to study its ability to modulate the complement system. Researchers have further processed the plant so that Aspilia pluriseta is prepared as extract fractions for testing cytotoxicity and antimicrobial properties. Additionally, the plant is prepared as root extracts to facilitate phytochemical characterization and the evaluation of antitubercular activity. These various preparation methods allow for the scientific validation of the plant's diverse therapeutic potential.
Parts used
Aspilia pluriseta is a medicinal plant recognized for its diverse biological activities across various morphological components. Research indicates that the leaves of this species possess significant antiviral properties, particularly against HIV-1. Additionally, extracts derived from the stem have demonstrated an interesting ability to modulate the complement system's inhibitory pathways. The root of the plant is also of high therapeutic interest, showing potent antimicrobial and antitubercular activities. Collectively, these studies of the leaves, stem, and roots validate the plant's potential as a source for discovering safe and effective new therapeutic agents.